Obseva Stock Today

OBSV -  USA Stock  

USD 1.89  0.01  0.53%

Market Performance
9 of 100
Odds Of Distress
Over 84
Obseva Sa is selling for under 1.89 as of the 25th of June 2022; that is -0.53% down since the beginning of the trading day. The stock's lowest day price was 1.84. Obseva Sa has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Obseva Sa are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of May 2022 and ending today, the 25th of June 2022. Click here to learn more.
CUSIP
H5861P103
Fiscal Year End
December
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
26th of January 2017
Category
Healthcare
Classification
Health Care
ISIN
CH0346177709
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland. Obseva Sa operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 77.97 M outstanding shares of which 3.85 M shares are now shorted by private and institutional investors with about 9.46 trading days to cover. More on Obseva Sa
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Obseva Sa Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Obseva Sa's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Obseva Sa or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Obseva Sa may become a speculative penny stock
Obseva Sa has very high historical volatility over the last 90 days
Obseva Sa has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 20.11 M. Net Loss for the year was (58.38 M) with profit before overhead, payroll, taxes, and interest of 17 K.
Obseva Sa currently holds about 54.73 M in cash with (70.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Latest headline from www.marketscreener.com: ObsEva Announces European Commission Marketing Authorization for Yselty, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids - Marketscreener.com
CEO, DirectorErnest Loumaye
Average Analyst Recommendation
Analysts covering Obseva Sa report their recommendations after researching Obseva Sa's financial statements, talking to executives and customers, or listening in on Obseva Sa's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Obseva Sa. The Obseva consensus assessment is calculated by taking the average forecast from all of the analysts covering Obseva Sa.
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Obseva Sa's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Obseva Sa (OBSV) is traded on NASDAQ Exchange in USA and employs 48 people. The company currently falls under 'Small-Cap' category with current market capitalization of 141.91 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Obseva Sa's market, we take the total number of its shares issued and multiply it by Obseva Sa's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Obseva Sa conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 77.97 M outstanding shares of which 3.85 M shares are now shorted by private and institutional investors with about 9.46 trading days to cover. Obseva Sa currently holds about 54.73 M in cash with (70.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Check Obseva Sa Probability Of Bankruptcy
Ownership
Obseva Sa owns a total of seventy-seven million nine hundred seventy thousand outstanding shares. Obseva Sa holds 5.25 pct. if its outstanding shares held by insiders and 5.25 pct. owned by third-party entities . Please note that no matter how much assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Obseva Ownership Details

Obseva Stock Price Odds Analysis

What are Obseva Sa's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Obseva Sa jumping above the current price in 90 days from now is about 17.53%. The Obseva Sa probability density function shows the probability of Obseva Sa stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2106. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Obseva Sa will likely underperform. Additionally, the company has an alpha of 0.0958, implying that it can generate a 0.0958 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 1.89HorizonTargetOdds Above 1.89
82.40%90 days
 1.89 
17.53%
Based on a normal probability distribution, the odds of Obseva Sa to move above the current price in 90 days from now is about 17.53 (This Obseva Sa probability density function shows the probability of Obseva Stock to fall within a particular range of prices over 90 days) .

Obseva Sa Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Obseva Sa market risk premium is the additional return an investor will receive from holding Obseva Sa long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Obseva Sa. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Obseva Sa's alpha and beta are two of the key measurements used to evaluate Obseva Sa's performance over the market, the standard measures of volatility play an important role as well.

Obseva Stock Against Markets

Picking the right benchmark for Obseva Sa stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Obseva Sa stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Obseva Sa is critical whether you are bullish or bearish towards Obseva Sa at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Obseva Sa without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Obseva Sa Corporate Directors

Obseva Sa corporate directors refer to members of an Obseva Sa board of directors. The board of directors generally takes responsibility for the Obseva Sa's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Obseva Sa's board members must vote for the resolution. The Obseva Sa board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Barbara Duncan - Independent DirectorProfile
James Healy - Independent DirectorProfile
Rafaele Tordjman - Independent DirectorProfile
Annette Clancy - Independent DirectorProfile

Investing Obseva Sa

You need to understand the risk of investing before taking a position in Obseva Sa. The danger of trading Obseva Sa is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Obseva Sa is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Obseva Sa. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Obseva Sa is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Your Equity Center. Note that the Obseva Sa information on this page should be used as a complementary analysis to other Obseva Sa's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Obseva Stock analysis

When running Obseva Sa price analysis, check to measure Obseva Sa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Obseva Sa is operating at the current time. Most of Obseva Sa's value examination focuses on studying past and present price action to predict the probability of Obseva Sa's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Obseva Sa's price. Additionally, you may evaluate how the addition of Obseva Sa to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Obseva Sa's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Obseva Sa. If investors know Obseva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Obseva Sa listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
156.5 M
Quarterly Revenue Growth YOY
0.5
Return On Assets
-0.31
Return On Equity
-1.3
The market value of Obseva Sa is measured differently than its book value, which is the value of Obseva that is recorded on the company's balance sheet. Investors also form their own opinion of Obseva Sa's value that differs from its market value or its book value, called intrinsic value, which is Obseva Sa's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Obseva Sa's market value can be influenced by many factors that don't directly affect Obseva Sa's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Obseva Sa's value and its price as these two are different measures arrived at by different means. Investors typically determine Obseva Sa value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Obseva Sa's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.